Selective degradation of targeted mRNAs using partially modified oligonucleotides.
Dagle
J M
JM
Department of Pediatrics, University of Iowa, Iowa City 52242, USA.
Weeks
D L
DL
D000818:Animals; D001483:Base Sequence; D019925:Cyclin A / Q000235:genetics; D019926:Cyclin B / Q000235:genetics; D056744:Cyclin B1; D004625:Embryo, Nonmammalian / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D007202:Indicators and Reagents; D020319:Oligodeoxyribonucleotides, Antisense / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D009865:Oocytes / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D016914:Ribonuclease H / Q000378:metabolism; D016415:Sequence Alignment; D014982:Xenopus laevis
D019925:Cyclin A; D019926:Cyclin B; D056744:Cyclin B1; D007202:Indicators and Reagents; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D016914:Ribonuclease H